Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 93Genitourinary 17Thoracic 16Breast 15Head & Neck 11Gynecologic 10Other hematologic neoplasm 4Other 4Lymphoid 4CNS 4Sarcoma 3Dermatologic 3Classical hematology 3Other neoplasm 1Endocrine 1

Conditions

Neuroendocrine Tumors 378Pituitary Neoplasms 159Multiple Endocrine Neoplasia Type 1 150Thyroid Cancer, Papillary 122Pheochromocytoma 107Carcinoma, Neuroendocrine 93Thyroid Neoplasms 74Paraganglioma 68Carcinoid Tumor 66Neoplasms 54Thyroid Carcinoma, Anaplastic 50Adrenocortical Carcinoma 47Adrenal Gland Neoplasms 46Neoplasm Metastasis 40Insulinoma 39Pancreatic Neoplasms 36Gastro-enteropancreatic neuroendocrine tumor 36Adenoma, Islet Cell 36Carcinoma, Medullary 29Neuroblastoma 28Adenocarcinoma, Follicular 28Hyperaldosteronism 25Prostatic Neoplasms 24Lung Neoplasms 24Obesity 23Brain Neoplasms 22Pituitary Diseases 21Differentiated Thyroid Cancer 20Cushing Syndrome 20Sarcoma 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Postoperative Complications × Endocrine × Clear all
NCT06221020 2024-01-24

To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

Chang Gung Memorial Hospital

Unknown
70 enrolled
Endocrine

Pituitary Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡